Health Condition 1: N839- Noninflammatory disorder of ovary,fallopian tube and broad ligament, unspecified Health Condition 2: N959- Unspecified menopausal and perimenopausal disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: a) ASA grade I & II patients b) Patients height 150-160 cm. c) Patients weight 40-60 kgs. d) Patients undergoing elective total abdominal hysterectomy lasting not more than 3 hours under Spinal Anesthesia. e) Patients willing to give informed and written consent
Exclusion criteria
Exclusion criteria: a) Patients with known history of allergy to study drugs used. b) Patients with features of infection over anterior abdominal wall. c) Patient unable to understand VAS (Visual Analogue Score). d) Patient who failed spinal anesthesia and have to convert to general anesthesia for total abdominal hysterectomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To compare the analgesic efficacy of combination of bupivacaine and dexmedetomidine to ropivacaine and dexmedetomidine in TAP (transversus abdominis plane) block after total abdominal hysterectomy via VAS (visual analogue score). 2.To include time to first rescue analgesia. Timepoint: 4hours post surgery 8hours post surgery 12hours post surgery 24hours post surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate hemodynamic changes in post operative period. 2. To assess any incidence of complications.Timepoint: Baseline 4hours post surgery 8hours post surgery 12hours post surgery 24 hours post surgery | — |
Countries
India
Contacts
Rajendra Institute Of Medical Sciences, Ranchi, Jharkhand, 834009